Related Experiment Video
Updated: Sep 11, 2025
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Analysis of nanomedicine primary tumor vs. metastasis targeting using clinical-stage core-crosslinked polymeric
Larissa Yokota Rizzo1, Federica De Lorenzi2, Saskia von Stillfried3
1Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Hospital, Aachen, North Rhine-Westphalia (NRW) 52074, Germany.
Abstract:
Targeting and treating metastatic cancer remain major clinical challenges. We developed an optically imageable metastatic mouse model based on near-infrared protein-expressing 4T1 triple-negative breast cancer cells. Using multimodal imaging, we studied the tumor and metastasis tropism of core-crosslinked polymeric micelles (CCPMs) as well as the antitumor and antimetastatic efficacy of clinical-stage docetaxel-loaded CCPMs (docetaxel-CCPMs). We show that nanomedicines effectively target metastases, albeit with lower efficiency than primary tumors. Tumor microenvironment analysis revealed that metastases are more vascularized than primary tumors but also present with higher levels of collagen crosslinking, thereby hindering nanomedicine accumulation. A comparison of mouse and human tumors and metastases showed similarities and differences, consistently demonstrating increased vascularization in metastases. In mice, docetaxel-CCPMs outperformed standard docetaxel in terms of efficacy and toxicity. These findings underscore the potential of nanomedicine to improve metastatic cancer therapy, and they offer new insights into the tumor and metastasis microenvironment as a determinant of targeted drug delivery.
Insights
This study developed an imageable metastatic breast cancer model to test nanomedicines. Nanomedicines target metastases effectively, showing improved efficacy and reduced toxicity compared to standard chemotherapy.
Area of Science:
- Oncology
- Nanomedicine
- Biomedical Engineering
Background:
- Metastatic cancer treatment remains a significant clinical challenge.
- Developing effective drug delivery systems for metastatic disease is crucial.
- Understanding the tumor microenvironment of metastases is key for targeted therapies.
Purpose of the Study:
- To develop an optically imageable metastatic mouse model for studying cancer metastasis.
- To investigate the tropism and efficacy of core-crosslinked polymeric micelles (CCPMs) loaded with docetaxel (docetaxel-CCPMs) in metastatic breast cancer.
- To analyze the tumor and metastasis microenvironment's impact on nanomedicine delivery.
Main Methods:
- Creation of an optically imageable 4T1 triple-negative breast cancer cell line for metastasis studies.
- Utilizing multimodal imaging to track nanomedicine distribution and assess therapeutic efficacy.
- Analyzing the microenvironment of primary tumors and metastases, including vascularization and collagen crosslinking.
Main Results:
- Nanomedicines demonstrated effective targeting of metastases, though with lower efficiency than primary tumors.
- Metastases exhibited increased vascularization but also higher collagen crosslinking compared to primary tumors, impacting nanomedicine accumulation.
- Docetaxel-CCPMs showed superior efficacy and reduced toxicity compared to standard docetaxel in mouse models.
Conclusions:
- Nanomedicines hold significant potential for improving the treatment of metastatic cancer.
- The tumor and metastasis microenvironment significantly influences targeted drug delivery efficacy.
- This study provides valuable insights into nanomedicine delivery and metastatic cancer therapy.
